Twenty-four patients were tested with an interferon-gamma release assay (IGRA) at the time of diagnosis, 22 with Quantiferon TB-Gold® (QFT.TB, Qiagen) and 2 with T-Spot.TB® (T-spot. This evidence concerns the gene IFNG and tuberculosis.